ArticleJHEP reports : innovation in hepatology2026
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trial.
Sadahisa Ogasawara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.